The inflammatory cytokine, interleukin‐1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Astrocytes remove glutamate from the synaptic cleft via specific transporters, and impaired glutamate reuptake may promote excitotoxic neuronal injury. In a model of viral encephalomyelitis caused by neuroadapted Sindbis virus (NSV), mice develop acute paralysis and spinal motor neuron degeneration inhibited by the AMPA receptor antagonist, NBQX. To investigate disrupted glutamate homeostasis in the spinal cord, expression of the main astroglial glutamate transporter, GLT‐1, was examined. GLT‐1 levels declined in the spinal cord during acute infection while GFAP expression was preserved. There was simultaneous production of inflammatory cytokines at this site, and susceptible animals treated with drugs that blocked IL‐1β release also limited paralysis and prevented the loss of GLT‐1 expression. Conversely, infection of resistant mice that develop mild paralysis following NSV challenge showed higher baseline GLT‐1 levels as well as lower production of IL‐1β and relatively preserved GLT‐1 expression in the spinal cord compared to susceptible hosts. Finally, spinal cord GLT‐1 expression was largely maintained following infection of IL‐1β‐deficient animals. Together, these data show that IL‐1β inhibits astrocyte glutamate transport in the spinal cord during viral encephalomyelitis. They provide one of the strongest in vivo links between innate immune responses and the development of excitotoxicity demonstrated to date.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · cited 1×
“Certainly, there are already approved compounds known to offer neuroprotection by increasing baseline astrocyte glutamate transporter expression (Rothstein et al. 2005).”
BackgroundWyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., & Suzumura, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600504200 · Cited by 749 · cited 1×
“Not only may endogenous immune cells such as microglia be direct sources of glutamate (Noda et al. 1999; Takeuchi et al. 2006; Barger et al. 2007), but their various inflammatory products may also alter synaptic glutamate homeostasis in a number of important ways.”
BackgroundThe Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476
LI, S., MALLORY, M., ALFORD, M., TANAKA, S., & MASLIAH, E. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00008 · Cited by 343
Szymocha, R., Akaoka, H., Dutuit, M., Malcus, C., Didier-Bazes, M., Belin, M.-F., & Giraudon, P. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6433-6441.2000 · Cited by 83 · cited 3×
“…105, 1276–1286 2008 The Authors mediators on EAAT expression and glutamate reuptake by astrocytes have been studied in vitro (Ye and Sontheimer 1996; Szymocha et al. 2000; Miralles et al. 2001; Wang et al. 2003; Korn et al. 2005), although direct proof that such mediators contribute to defects in…”
Background
Cited by
Starkey, J., Kobayashi, N., Numaguchi, Y., & Moritani, T. (2017) · RadioGraphics · doi:10.1148/rg.2017160085 · Cited by 312
Gwak, Y. S., Kang, J., Unabia, G. C., & Hulsebosch, C. E. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.010 · Cited by 270
Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases
Cekanaviciute, E., & Buckwalter, M. S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0477-8 · Cited by 229
“However, inflammation can also impair astrocytic uptake of glutamate, further exacerbating neuronal damage [100], which would, in turn, increase neuroinflammation.”
BackgroundTakaki, J., Fujimori, K., Miura, M., Suzuki, T., Sekino, Y., & Sato, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-275 · Cited by 173
Sompol, P., Furman, J. L., Pleiss, M. M., Kraner, S. D., Artiushin, I. A., Batten, S. R., Quintero, J. E., Simmerman, L. A., Beckett, T. L., Lovell, M. A., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0877-17.2017 · Cited by 123
Metadata
- Authors
- Prow, N. A., & Irani, D. N.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2008-01-13
- Volume
- 105
- Issue
- 4
- Pages
- 1276-1286
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2114406859
- Cited by
- 126
- References
- 8
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The inflammatory cytokine, interleukin‐1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. https://app.cochat.ai/papers/10.1111/j.1471-4159.2008.05230.x
- The paper
- Prow, N. A., & Irani, D. N. (2008). The inflammatory cytokine, interleukin‐1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2008.05230.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.